AUTUMN WEBB: Open Payments
NPI 1356900351 · WEST GROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 29 payments from 20 companies in 2025. Trend: 2023 $712 · 2024 $138 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $204 |
| Alexion Pharmaceuticals, Inc. | 1 | $128 |
| SpringWorks Therapeutics, Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $107 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Incyte Corporation | 2 | $44 |
| Lilly USA, LLC | 1 | $26 |
| Astellas Pharma US Inc | 1 | $26 |
| Aveo Pharmaceuticals, Inc. | 1 | $26 |
Products named: RYBREVANT, OGSIVEO, KEYTRUDA, JAKAFI, VERZENIO, Enhertu, Vyloy, FOTIVDA.
Industry payments across PA — which companies pay providers there.
